Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05737693 · ClinicalTrials.gov registry record · Phase 2

Enhancing Week-long Psychological Treatment for PTSD With Ketamine

A Phase 2 study of Posttraumatic Stress Disorder, sponsored by Yale University.

Recruiting
Registry status
Phase 2
Development phase
162
Enrollment target
2
Study locations

NCT05737693 is a Phase 2 study of Posttraumatic Stress Disorder that is actively recruiting participants, run by Yale University. The registered enrollment target is 162 participants, above the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (46% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05737693, a Phase 2 study of Posttraumatic Stress Disorder, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
Phase 2
Development phase
162 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to test if the combination of ketamine, vs midazolam, with an intensive trauma-focused psychotherapy will be more effective in relieving post-traumatic stress disorder (PTSD). This week-long treatment has the potential to produce a significant therapeutic effect that otherwise would take months to occur. The study will also focus on learning about the neurophysiological changes produced by the proposed clinical trial.

Conditions Studied

Posttraumatic Stress Disorder

Interventions

  • DRUG Ketamine
  • DRUG Midazolam

Study Locations (2)

Connecticut

  • Yale University School of Medicine - New Haven

Other

  • Tel Aviv University - Tel Aviv

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2023-08-21
Est. Completion 2031-08-01
Phase Phase 2

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05737693

The ClinicalTrials.gov registry entry for NCT05737693 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (46% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.

NCT05737693 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Other.

Frequently Asked Questions

What is clinical trial NCT05737693 about?

NCT05737693 is a clinical study titled "Enhancing Week-long Psychological Treatment for PTSD With Ketamine". The purpose of this study is to test if the combination of ketamine, vs midazolam, with an intensive trauma-focused psychotherapy will be more effective in relieving post-traumatic stress disorder (PTSD). This week-long treatment has the potential to produce a significant therapeutic effect that oth...

What is the current status of trial NCT05737693?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 162 participants. The study started on 2023-08-21. Estimated completion is 2031-08-01.

What conditions does trial NCT05737693 study?

This clinical trial studies the following conditions: Posttraumatic Stress Disorder.

What interventions are being tested in trial NCT05737693?

The interventions under investigation include: Ketamine (DRUG), Midazolam (DRUG).

Who is sponsoring clinical trial NCT05737693?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05737693 being conducted?

This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Posttraumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Posttraumatic Stress Disorder

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.